Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Union Minister for Commerce & Industry Piyush Goyal announced that India has achieved a landmark milestone, as there are 75000 startups in the country.
EXAMIANS